Results
eNauka >
Rezultati >
Neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: 3-year analysis from a phase 3 randomized, placebo-controlled, double-blind trial (ExteNET)
| Naziv: | Neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: 3-year analysis from a phase 3 randomized, placebo-controlled, double-blind trial (ExteNET) | Autori  : | Chan, A; ...; Neskovic-Konstantinovic, Zora B; ...; (broj, koautora 23) | Godina: | 2016 | Publikacija: | CANCER RESEARCH | ISSN: | 0008-5472 Cancer Research Pretraži identifikator |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 76 br. 4_Supplement str. S5-02 | DOI: | 10.1158/1538-7445.SABCS15-S5-02 | WoS-ID: | 000375622400028 | URI: | https://enauka.gov.rs/handle/123456789/821204 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.